E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 

Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each.


Click on the deal summary to see the full details.

GlaxoSmithKline Capital Inc. 0.700% due 3/18/2016

GlaxoSmithKline Capital Inc. 2.800% due 3/18/2023

GlaxoSmithKline Capital Inc. 4.200% due 3/18/2043

GlaxoSmithKline Capital Inc. L+62.5 due 5/13/2010

GlaxoSmithKline Capital Inc. 4.850% due 5/15/2013

GlaxoSmithKline Capital Inc. 5.650% due 5/15/2018

GlaxoSmithKline Capital Inc. 6.375% due 5/15/2038



© 2012 Prospect News.
All content in this database is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.